<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03628157</url>
  </required_header>
  <id_info>
    <org_study_id>Bone augmentation</org_study_id>
    <nct_id>NCT03628157</nct_id>
  </id_info>
  <brief_title>GBR With Ptfe With Bovine Bone With and Without Autogenous</brief_title>
  <official_title>Ridge Augmentation in Atrophic Anterior Maxillary Ridges With a Titanium Reinforced Polytetraflouroethelene Membrane and Anorganic Bovine Bone-Derived Mineral With and Without Particulated Autogenous Bone Chips</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ridge Augmentation in Atrophic Anterior Maxillary Ridges with a Titanium Reinforced
      Polytetraflouroethelene Membrane and Anorganic Bovine Bone-Derived Mineral in intervention
      group and Anorganic Bovine Bone-Derived Mineralwith Particulated Autogenous Bone Chips in
      control group.

      CBCT will be done before surgery, immediate after surgery and 6 month to compare the bone
      gain in mm.

      Bone sample will be collected during exposure after 6 month of surgery by trephine bur to
      assess the bone quality through histo-morphometric analysis in order to determine the size,
      shape and orientation of the bony trabeculae, the size and porosity of the bony cortex in
      addition to the new bone/ bone substitute ratio

        -  1ry outcome: Amount of bone gain will be measured using linear measurements from CBCT
           immediate after surgery and after 6 month.

        -  2ry outcome: a bone sample will be collected and analyzed under histo-morphometric
           analysis.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2018</start_date>
  <completion_date type="Anticipated">August 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Amount of bone gain (height and width in mm)</measure>
    <time_frame>6 months</time_frame>
    <description>will be measured using linear measurements from CBCT</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>a bone sample will be collected and analyzed under histo-morphometric analysis. (no of bone cells in cubic mm)</measure>
    <time_frame>6 months</time_frame>
    <description>a bone sample will be collected and analyzed under histo-morphometric analysis.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Atrophied Anterior Maxillary Ridges</condition>
  <arm_group>
    <arm_group_label>intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>using a bio-oss bovine bone alone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>using a bio-oss bovine bone with autogenous bone ratio 1:1</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Geistlich Bio-Oss® bovine bone alone</intervention_name>
    <description>Ridge augmentation by titanium reinforced polytetraflouroethelene membrane and anorganic bovine bone derived mineral alone</description>
    <arm_group_label>control</arm_group_label>
    <arm_group_label>intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  • Patients with atrophied anterior maxillary ridge area.

               -  Age: 18 years and older.

               -  Both sexes.

               -  No intraoral soft and hard tissue pathology.

               -  No systemic condition that contraindicate bone augmentation

        Exclusion Criteria:

          -  • Heavy smokers more than 20 cigarettes per day.(32)

               -  Patients with systemic disease that may affect normal healing.

               -  Psychiatric problems.

               -  Disorders to bone augmentation are related to history of radiation therapy to the
                  head and neck neoplasia.

               -  Pregnant or nursing women.

               -  Patients with uncontrolled diabetes mellitus, rheumatoid arthritis or
                  osteoporosis.

               -  Patient with previous history of radiotherapy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>sherif hegazy, bachelor</last_name>
    <phone>00201008183867</phone>
    <email>shekosoa@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of Oral and Dental Medicine</name>
      <address>
        <city>Giza</city>
        <zip>12613</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <contact>
      <last_name>hassan A ahmed, bachelor</last_name>
      <phone>(+202) 23642938</phone>
      <email>hassan.ahmed@dentistry.cu.edu.eg</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>August 7, 2018</study_first_submitted>
  <study_first_submitted_qc>August 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2018</study_first_posted>
  <last_update_submitted>August 13, 2018</last_update_submitted>
  <last_update_submitted_qc>August 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Sherif osama hegazy</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrophy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

